Clinical trial / 2022
In people with cardiovascular risk factors, dried purple-black barberry consumption significantly lowered plasma lipids and CRP compared to placebo.
An 8-week single-blind randomized controlled trial evaluated the effects of 10 g/day dried barberry versus placebo in 84 participants with cardiovascular risk factors. Body weight, BMI, physical activity, and dietary intake did not differ between groups. After adjusting for baseline values, the barberry group showed significant decreases compared to placebo in TG (p < 0.001), TC (p = 0.011), LDL-C (p = 0.015), sd-LDL-C (p = 0.019), non-HDL-C (p = 0.004), TC/HDL-C (p = 0.039), and CRP (p = 0.020).
- Study type
- 8-week single-blinded randomized controlled trial
- Who was studied
- 84 participants with cardiovascular risk factors (mean age 54.06 ± 10.19 years)
- What was measured
- Plasma lipid profile and inflammatory biomarkers (CRP and IL-6)
THE PAPER
The effect of barberry (Berberis integerrima) on lipid profile and systemic inflammation in subjects with cardiovascular risk factors: a randomized controlled trial.
Emamat H, Zahedmehr A, Asadian S, Nasrollahzadeh J. BMC Complement Med Ther, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.